Cooley

Lindsey O'Crump

Deals
4
Latest
May 2026
Most deals in
Biotech

Firm

  • Cooley Law firm · 2026 · 4 deals
Deals by year
Lindsey O'Crump: deals by year0123420252026 YTD: 3 M&A2026 YTD: 1 Equity raisings42026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Lindsey O'Crump was named on, most recent first
May 2026 Engage Bio –Eli LillyAcquisitionLegal adviser to Engage Bio (target)Announced202.0Biotech+1Eli Lilly acquisition of Engage Bio
May 2026 Candid Therapeutics –UCBAcquisitionLegal adviser to Candid Therapeutics (target)Announced2,200.0Biotech+1UCB acquisition of Candid Therapeutics
Mar 2026 Candid Therapeutics ––PlacementLegal adviser to the issuerPending505.0Biotech+1Candid Therapeutics placement
Feb 2026 35Pharma –GSKAcquisitionLegal adviser to 35Pharma (target)Announced950.0Biotech+1GSK acquisition of 35Pharma

Deals where Lindsey O'Crump is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.